Chemical Structure (Exxua 1)
Exxua Tablet, Extended Release
Product Images NDC 23594-151
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Exxua (NDC 23594-151). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aytu Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Exxua 2)
This text provides information on demographic groups (Asian/White) and age ranges for males and females, along with categories for renal impairment (mild, moderate, severe) and hepatic impairment (mild, moderate). Additionally, the text shows a scale (0, 1, 2, 3) indicating changes relative to a reference point.*
Figure 2 (Exxua 3)
This is a table showing the interacting compound PK (pharmacokinetics) including Mean Effect and 90% CI (confidence interval) for various drugs like Ketoconazole, Lithium, Paroxetine, Verapamil, and Warfarin. It provides information on the change relative to a reference, which is Gabapentin (363 mg) administered with interacting drugs except for Verapamil. The data includes AUC, Cmax (maximum concentration), and details on the geometric mean ratios.*
Figure 3 (Exxua 4)
This text appears to provide information about a clinical trial comparing the mean change from baseline in HAMD-17 total score between a medication (possibly named 'EXXUA 18210 72.6 mg/day') and a placebo group. The analysis is based on least squares estimates and standard errors. The number of patients in each group (Exwa and Placebo) is not clearly legible.*
18.2 mg (Exxua 5)
Not available.*
36.3 mg (Exxua 6)
54.5 mg (Exxua 7)
72.6 mg (Exxua 8)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
